title: Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
abstract: Gliomas are the most aggressive of all human malignancies. Survivin is overexpressed in gliomas, and overexpression of survivin is associated with the progression of gliomas and the poor prognosis of glioma patients. Arsenic trioxide (ATO) is used in patients with acute promyelocytic leukemia and is active in vitro in several solid tumor cell lines. In the present study, the human glioma cell line U118-MG was used to investigate the anti-cancer effect of ATO in vitro and in vivo. The molecular mechanisms of the relationship between cell death (autophagy and apoptosis) and survivin were analyzed. ATO reduced cell viability through an increase in mitotic cells in a concentration-dependent manner. The mechanisms of ATO-induced autophagy and apoptosis were mediated by the inhibition of PI3K/Akt and the activation of MAPK signaling pathways. The ATO treatment of U118-MG cells pre-treated with specific chemical inhibitors of PI3K/AKT and MAPK significantly changed the cytotoxicity and the expression of survivin, suggesting that survivin plays a pivotal role in ATO-induced cell death. When U118-MG cells were transfected with survivin shRNA, the results demonstrated a significant increase in apoptotic and autophagic cells. In in vivo studies, the ATO treatment of SCID mice showed a significant tumor growth delay time and the decreased expression of survivin in tumor tissue. An important result from the current study is the finding that survivin could suppress both autophagy and apoptosis in glioma cells. This study suggests that ATO treatment or survivin inhibition could be a novel therapeutic strategy in malignant gliomas.
authors: Department of Environmental and Occupational Health, National Cheng Kung University Medical College, 138 Sheng-Li Road, Tainan 704, Taiwan.
authors: Hui-Wen
authors: HW
authors: Chiu
authors: Yuan-Soon
authors: YS
authors: Ho
authors: Ying-Jan
authors: YJ
authors: Wang
references: FEBS J. 2011 Feb;278(3):403-13
references: 21182587
references: Leukemia. 2003 Jul;17(7):1333-7
references: 12835721
references: J Cell Physiol. 2005 Feb;202(2):623-34
references: 15316930
references: Neoplasia. 2010 May;12(5):376-87
references: 20454509
references: Chin Med J (Engl). 2004 Apr;117(4):612-4
references: 15109460
references: Autophagy. 2010 Apr;6(3):353-65
references: 20200477
references: Blood. 2003 May 15;101(10):4078-87
references: 12531793
references: Cancer Lett. 2009 Nov 1;284(2):208-15
references: 19457607
references: Autophagy. 2009 Apr;5(3):430-1
references: 19202353
references: Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12288-93
references: 17640917
references: Eur J Cancer Clin Oncol. 1987 Aug;23(8):1189-96
references: 3653212
references: Met Ions Biol Med. 2010 May 1;7(5):1996-2007
references: 20454603
references: Cancer Biol Ther. 2010 Aug 1;10(3):251-7
references: 20592496
references: J Biol Chem. 2008 Sep 5;283(36):25057-73
references: 18611860
references: Mol Cancer. 2009 Nov 12;8:100
references: 19909554
references: J Mol Med (Berl). 2009 Nov;87(11):1123-32
references: 19763526
references: Cancer Treat Rev. 2009 Nov;35(7):553-62
references: 19559538
references: Cancer. 2005 Dec 15;104(12):2775-83
references: 16284993
references: Science. 2002 Dec 6;298(5600):1911-2
references: 12471242
references: Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6332-7
references: 16601104
references: Toxicol Sci. 2009 Aug;110(2):376-88
references: 19451193
references: Int J Environ Res Public Health. 2010 May;7(5):1996-2007
references: 20632473
references: PLoS One. 2010 Apr 02;5(4):e9996
references: 20368806
references: Arch Toxicol. 2006 Jun;80(6):310-8
references: 16328441
references: J Biol Chem. 2003 Sep 26;278(39):37832-9
references: 12853461
references: J Cell Biochem. 2008 Oct 15;105(3):678-87
references: 18668508
references: Oncogene. 2001 Oct 29;20(49):7146-53
references: 11704843
references: Cancer Lett. 2009 Mar 8;275(1):54-60
references: 19010591
references: J Pharmacol Exp Ther. 2006 Jul;318(1):142-51
references: 16614167
references: Int J Oncol. 2007 Nov;31(5):1111-7
references: 17912437
references: Autophagy. 2010 Apr;6(3):322-9
references: 20224296
references: Autophagy. 2009 Nov;5(8):1092-8
references: 19786835
references: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83
references: 15070760
references: Nat Rev Cancer. 2008 Jan;8(1):61-70
references: 18075512
references: Cell. 1993 Aug 27;74(4):609-19
references: 8358790
references: Cancer Cell. 2006 Mar;9(3):157-73
references: 16530701
references: Autophagy. 2009 Apr;5(3):410-2
references: 19197142
references: FEBS Lett. 2002 May 22;519(1-3):195-200
references: 12023044
references: Oncogene. 2005 Mar 10;24(11):1904-13
references: 15674346
references: Blood. 2005 May 15;105(10):4013-20
references: 15665116
references: Int J Oncol. 2009 Mar;34(3):729-42
references: 19212678
references: Autophagy. 2009 May;5(4):472-83
references: 19242099
references: J Cell Physiol. 2008 Oct;217(1):23-33
references: 18412143
references: Toxicol Sci. 2010 Jul;116(1):183-93
references: 20403967
references: Head Neck. 2011 May;33(5):734-42
references: 20737493
references: Mol Biol Rep. 2008 Sep;35(3):421-9
references: 17530438
references: Int J Environ Res Public Health. 2010 May;7(5):2018-32
references: 20623008
references: Cancer. 2003 Feb 15;97(4):1077-83
references: 12569609
references: Clin Cancer Res. 2010 Sep 1;16(17):4311-2
references: 20622048